Post-Menopausal Osteoporosis Clinical Trials

A listing of Post-Menopausal Osteoporosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 10 clinical trials
Denosumab Biosimilar Injection in Post Menopausal Women With Osteoporosis

Denosumab of Intas is biosimilar denosumab candidate under development by Intas Pharmaceutical Limited (Biopharma Division). Denosumab of Intas is already approved by Indian drug licensing authority- Drug Controller General (India) for marketing in Indian population since 2018.As per regulatory requirement, a comparative clinical study to establish Pharmacokinetic, Pharmacodynamic and Immunogenicity …

dual-energy x-ray absorptiometry
prolia
denosumab
spotting
serum fsh level
  • 0 views
  • 04 Oct, 2022
  • 1 location
A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of MB09 [Proposed Denosumab Biosimilar] to Prolia® [EU-sourced] in Postmenopausal Osteoporosis (SIMBA Study)

This is a randomized, double-blind, parallel, multicenter, multinational study to compare the efficacy, pharmacokinetics, pharmacodynamics, safety and immunogenicity of MB09 versus Prolia® in postmenopausal women with osteoporosis

  • 0 views
  • 07 Oct, 2022
  • 47 locations
Study on Vascular Function, Sarcopenia and Pain in Treated Postmenopausal Osteoporosis (VASCO)

This study aims to follow a cohort of osteoporotic patients treated with anti-osteoporotic drugs and to evaluate the impact of these treatments on the osteoporosis-cardiovascular-sarcopenia triad and on pain.

  • 0 views
  • 24 Oct, 2022
  • 1 location
Multicenter Study in Postmenopausal Women With Osteoporosis, ALVOBOND (ALVOBOND)

This is a randomized, double-blind, parallel design, repeat dose, 2 arm, multicenter study comparing the efficacy, safety, immunogenicity, and PK profiles of AVT03 and Prolia in postmenopausal women with osteoporosis. After the screening activities, eligible subjects will be randomized in a 1:1 ratio to receive either AVT03 60 mg or …

denosumab
prolia
  • 0 views
  • 07 Oct, 2022
  • 1 location
A Phase 3 Study to Compare Biosimilar Denosumab With Prolia®

This is a phase 3 Randomized, Double-blind, Parallel-group, Active-controlled Study to Compare the Efficacy, Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Enzene Denosumab (ENZ215) and Prolia® in Postmenopausal Women with Osteoporosis

denosumab
postmenopausal osteoporosis
prolia
x-ray absorptiometry
  • 0 views
  • 04 Oct, 2022
  • 1 location
Anabolic Therapy in Postmenopausal Osteoporosis

In this research study we want to learn more about the effect of two different FDA-approved medications in the treatment of osteoporosis.

Accepts healthy volunteers
postmenopausal osteoporosis
denosumab
romosozumab
  • 0 views
  • 04 Oct, 2022
  • 1 location
Efficacy and Safety of JMT103 in the Treatment of Postmenopausal Women With Osteoporosis

This study is to evaluate the efficacy and safety of JMT103 in the treatment of postmenopausal women with osteoporosis.

x-rays
dual-energy x-ray absorptiometry
denosumab
x-ray absorptiometry
  • 0 views
  • 04 Oct, 2022
  • 1 location
Romosozumab Use to Build Skeletal Integrity (RUBI)

The purpose of this study is to find out if one year of romosozumab (Evenity®), a monthly injection given in the arm under the skin, prior to an infusion of zoledronic acid Reclast®, works to treat bone loss and prevent it from worsening in older women (ages 65 and older) …

calcium
fragility fracture
romosozumab
vitamin d
osteoporotic fracture
  • 0 views
  • 07 Oct, 2022
  • 1 location
Effect of GLP-1 Receptor Agonists on Trabecular Bone Score and Visceral Adiposity in Postmenopausal Women With Type 2 Diabetes Mellitus.

This study will help determine the effect of Glucagon Like Peptide-1 (GLP-1)receptor agonists on bone strength in postmenopausal women with type 2 diabetes mellitus (T2DM)

  • 0 views
  • 04 Oct, 2022
  • 1 location
Psychological déterminants of the Therapeutic Observance of Osteoporotic Patients (OSTEOPSY)

Osteoporosis is a skeletal pathology characterized by decreased bone mass and deterioration of bone tissue. This pathology affects predominantly women, which is estimated that 40% of them will suffer an osteoporotic fracture. The incidence of osteoporosis, thus representing a major public health problem where osteoporotic fractures have a higher incidence …

osteoporotic fracture
calcium
bone destruction
osteoporosis
bone mineral density
  • 12 views
  • 27 Oct, 2022
  • 1 location